These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25189222)

  • 61. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?
    Sridharan P; Chamberlain RS
    Surg Infect (Larchmt); 2013 Dec; 14(6):489-511. PubMed ID: 24274059
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Association of kidney function with effectiveness of procalcitonin-guided antibiotic treatment: a patient-level meta-analysis from randomized controlled trials.
    Heilmann E; Gregoriano C; Wirz Y; Luyt CE; Wolff M; Chastre J; Tubach F; Christ-Crain M; Bouadma L; Annane D; Damas P; Kristoffersen KB; Oliveira CF; Stolz D; Tamm M; de Jong E; Reinhart K; Shehabi Y; Verduri A; Nobre V; Nijsten M; deLange DW; van Oers JAH; Beishuizen A; Girbes ARJ; Mueller B; Schuetz P
    Clin Chem Lab Med; 2020 Sep; 59(2):441-453. PubMed ID: 32986609
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Procalcitonin, a valuable biomarker assisting clinical decision-making in the management of community-acquired pneumonia.
    Lindstrom ST; Wong EK
    Intern Med J; 2014 Apr; 44(4):390-7. PubMed ID: 24528892
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Procalcitonin and pyuria-based algorithm reduces antibiotic use in urinary tract infections: a randomized controlled trial.
    Drozdov D; Schwarz S; Kutz A; Grolimund E; Rast AC; Steiner D; Regez K; Schild U; Guglielmetti M; Conca A; Reutlinger B; Ottiger C; Buchkremer F; Haubitz S; Blum C; Huber A; Buergi U; Schuetz P; Bock A; Fux CA; Mueller B; Albrich WC
    BMC Med; 2015 May; 13():104. PubMed ID: 25934044
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Evaluation of procalcitonin as a marker to predict antibiotic response in adult patients with acute appendicitis: a prospective observational study.
    Assarsson J; Körner U; Lundholm K
    Surg Infect (Larchmt); 2014 Oct; 15(5):601-5. PubMed ID: 24865123
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.
    Tanrıverdi H; Örnek T; Erboy F; Altınsoy B; Uygur F; Atalay F; Tor MM
    Wien Klin Wochenschr; 2015 Oct; 127(19-20):756-63. PubMed ID: 25586444
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment of sepsis patients].
    Xu XL; Yan FD; Yu JQ; Chen QH; Lin H; Zheng RQ
    Zhonghua Yi Xue Za Zhi; 2017 Feb; 97(5):343-346. PubMed ID: 28219190
    [No Abstract]   [Full Text] [Related]  

  • 68. Procalcitonin-guided protocol is not useful to manage antibiotic therapy in febrile neutropenia: a randomized controlled trial.
    Lima SS; Nobre V; de Castro Romanelli RM; Clemente WT; da Silva Bittencourt HN; Melo AC; Salomão LC; Serufo JC
    Ann Hematol; 2016 Jun; 95(7):1169-76. PubMed ID: 27118539
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD.
    Soler N; Esperatti M; Ewig S; Huerta A; Agustí C; Torres A
    Eur Respir J; 2012 Dec; 40(6):1344-53. PubMed ID: 22523352
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The use of a standardized PCT-algorithm reduces costs in intensive care in septic patients - a DRG-based simulation model.
    Wilke MH; Grube RF; Bodmann KF
    Eur J Med Res; 2011 Dec; 16(12):543-8. PubMed ID: 22112361
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [The value of serum procalcitonin in treatment of community acquired pneumonia in outpatient].
    Long W; Deng XQ; Tang JG; Xie J; Zhang YC; Zhang Y; Gao YY; Lu G
    Zhonghua Nei Ke Za Zhi; 2009 Mar; 48(3):216-9. PubMed ID: 19576090
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Role of procalcitonin in monitoring the antibiotic therapy in septic surgical patients].
    Pundiche M; Sârbu V; Unc OD; Grasa C; Martinescu A; Bădărău V; Durbală I; Sapte E; Pasăre R; Voineagu L; Iordache I; Vâncă A; Adam A
    Chirurgia (Bucur); 2012; 107(1):71-8. PubMed ID: 22480120
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial.
    Jensen JU; Hein L; Lundgren B; Bestle MH; Mohr TT; Andersen MH; Thornberg KJ; Løken J; Steensen M; Fox Z; Tousi H; Søe-Jensen P; Lauritsen AØ; Strange D; Petersen PL; Reiter N; Hestad S; Thormar K; Fjeldborg P; Larsen KM; Drenck NE; Ostergaard C; Kjær J; Grarup J; Lundgren JD;
    Crit Care Med; 2011 Sep; 39(9):2048-58. PubMed ID: 21572328
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial.
    Christ-Crain M; Stolz D; Bingisser R; Müller C; Miedinger D; Huber PR; Zimmerli W; Harbarth S; Tamm M; Müller B
    Am J Respir Crit Care Med; 2006 Jul; 174(1):84-93. PubMed ID: 16603606
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial.
    Kyriazopoulou E; Liaskou-Antoniou L; Adamis G; Panagaki A; Melachroinopoulos N; Drakou E; Marousis K; Chrysos G; Spyrou A; Alexiou N; Symbardi S; Alexiou Z; Lagou S; Kolonia V; Gkavogianni T; Kyprianou M; Anagnostopoulos I; Poulakou G; Lada M; Makina A; Roulia E; Koupetori M; Apostolopoulos V; Petrou D; Nitsotolis T; Antoniadou A; Giamarellos-Bourboulis EJ
    Am J Respir Crit Care Med; 2021 Jan; 203(2):202-210. PubMed ID: 32757963
    [No Abstract]   [Full Text] [Related]  

  • 76. Biological markers to determine eligibility in trials for community-acquired pneumonia: a focus on procalcitonin.
    Niederman MS
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S127-32. PubMed ID: 18986278
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Design and rationale of the Procalcitonin Antibiotic Consensus Trial (ProACT), a multicenter randomized trial of procalcitonin antibiotic guidance in lower respiratory tract infection.
    Huang DT; Angus DC; Chang CH; Doi Y; Fine MJ; Kellum JA; Peck-Palmer OM; Pike F; Weissfeld LA; Yabes J; Yealy DM;
    BMC Emerg Med; 2017 Aug; 17(1):25. PubMed ID: 28851296
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Diagnostic value of serum procalcitonin in identifying the etiology of non-responding community-acquired pneumonia after initial antibiotic therapy].
    Wang Z; Zhang X; Wu J; Zhang W; Kuang H; Li X; Xuan W; Wang K; Ma L
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Nov; 37(11):824-30. PubMed ID: 25604112
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials.
    Kopterides P; Siempos II; Tsangaris I; Tsantes A; Armaganidis A
    Crit Care Med; 2010 Nov; 38(11):2229-41. PubMed ID: 20729729
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Serum procalcitonin: a reliable tool for the diagnosis and follow-up of neonatal bacterial infections in Sub-Saharan Africa].
    Alima Yanda AN; Kobela M; Nansseu JR; Taguebue J; Boula A; Eposse C; Monono N; Ngo Um-Sap S; Gervaix A; Koki Ndombo PO
    Arch Pediatr; 2015 Oct; 22(10):1015-20. PubMed ID: 26160140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.